Neuroprotection in Stroke w/ Recombinant Fusion Protein

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$100,000.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43NS051076-01
Agency Tracking Number:
NS051076
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
ARMAGEN TECHNOLOGIES, INC.
ARMAGEN TECHNOLOGIES, INC., 914 COLORADO BLVD, SANTA MONICA, CA, 90401
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
RUBEN Boado
() -
Business Contact:
(310) 917-1275
Research Institution:
n/a
Abstract
DESCRIPTION (PROVIDED BY APPLICANT): Stroke is the third leading cause of death and affects nearly 1 million people in the U.S. each year. The cost for rehabilitation of stroke survivors is over $40 billion per year in the U.S. The debilitating effect

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government